Immune modification therapy for myasthenia gravis

Myasthenia gravis is an autoimmune disease that is primarily mediated by acetylcholine receptor antibodies involving the neuromuscular junction.Immunomodification therapy can significantly reduce the mortality and improve the quality of social life of myasthenia gravis patients, but there are many kinds of immunosuppressants and dose-related adverse reactions.And so far, there is no definite conclusion on the selection and the specific use of immunosuppressants.This review summarized the clinical application of immunotherapy in myasthenia gravis, so as to provide a reference for clinicians in the treatment of myasthenia gravis. Key words: Myasthenia gravis; Immunomodified therapy; Immunosuppressive agents; Side effects